Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6152 | 1458 | 50.8 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VACCINE DELIVERY | Author keyword | 26 | 30% | 5% | 72 |
| 2 | PLG MICROPARTICLES | Author keyword | 15 | 82% | 1% | 9 |
| 3 | ADJUVANT UNIT | Address | 11 | 100% | 0% | 6 |
| 4 | GANTREZ R AN | Author keyword | 11 | 100% | 0% | 6 |
| 5 | SINGLE SHOT VACCINE | Author keyword | 11 | 78% | 0% | 7 |
| 6 | ANTIGEN DELIVERY | Author keyword | 10 | 26% | 2% | 33 |
| 7 | NASAL VACCINATION | Author keyword | 9 | 44% | 1% | 16 |
| 8 | CDDR | Address | 9 | 83% | 0% | 5 |
| 9 | INFECT DIS IMMUNOL VACCINE DELIVERY FORMUL | Address | 9 | 83% | 0% | 5 |
| 10 | VACCINE NANOTECHNOL | Address | 8 | 75% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | VACCINE DELIVERY | 26 | 30% | 5% | 72 | Search VACCINE+DELIVERY | Search VACCINE+DELIVERY |
| 2 | PLG MICROPARTICLES | 15 | 82% | 1% | 9 | Search PLG+MICROPARTICLES | Search PLG+MICROPARTICLES |
| 3 | GANTREZ R AN | 11 | 100% | 0% | 6 | Search GANTREZ+R+AN | Search GANTREZ+R+AN |
| 4 | SINGLE SHOT VACCINE | 11 | 78% | 0% | 7 | Search SINGLE+SHOT+VACCINE | Search SINGLE+SHOT+VACCINE |
| 5 | ANTIGEN DELIVERY | 10 | 26% | 2% | 33 | Search ANTIGEN+DELIVERY | Search ANTIGEN+DELIVERY |
| 6 | NASAL VACCINATION | 9 | 44% | 1% | 16 | Search NASAL+VACCINATION | Search NASAL+VACCINATION |
| 7 | TREHALOSE 6 6 DIBEHENATE | 8 | 100% | 0% | 5 | Search TREHALOSE+6+6++DIBEHENATE | Search TREHALOSE+6+6++DIBEHENATE |
| 8 | VACCINE DELIVERY SYSTEM | 8 | 48% | 1% | 12 | Search VACCINE+DELIVERY+SYSTEM | Search VACCINE+DELIVERY+SYSTEM |
| 9 | NASAL IMMUNIZATION | 7 | 34% | 1% | 17 | Search NASAL+IMMUNIZATION | Search NASAL+IMMUNIZATION |
| 10 | TETANUS TOXOID | 7 | 15% | 3% | 39 | Search TETANUS+TOXOID | Search TETANUS+TOXOID |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CONTROLLED RELEASE MICROPARTICLES | 26 | 80% | 1% | 16 |
| 2 | BIODEGRADABLE MICROPARTICLES | 24 | 28% | 5% | 73 |
| 3 | BIODEGRADABLE MICROSPHERES | 23 | 16% | 9% | 129 |
| 4 | POLYGAMMA GLUTAMIC ACID NANOPARTICLES | 21 | 73% | 1% | 16 |
| 5 | TMC NANOPARTICLES | 19 | 80% | 1% | 12 |
| 6 | CATIONIC MICROPARTICLES | 19 | 36% | 3% | 43 |
| 7 | VACCINE DELIVERY | 18 | 24% | 4% | 64 |
| 8 | PARTICULATE VACCINES | 18 | 89% | 1% | 8 |
| 9 | BIODEGRADABLE POLYMER MICROSPHERES | 17 | 62% | 1% | 18 |
| 10 | POLYDL LACTIDE CO GLYCOLIDE MICROSPHERES | 16 | 45% | 2% | 27 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Nanoparticle vaccines | 2014 | 34 | 187 | 35% |
| Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses | 2010 | 105 | 94 | 62% |
| Polymeric particles in vaccine delivery | 2010 | 61 | 57 | 72% |
| Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens | 2005 | 237 | 111 | 58% |
| Engineering synthetic vaccines using cues from natural immunity | 2013 | 42 | 117 | 30% |
| Biomaterials for Nanoparticle Vaccine Delivery Systems | 2014 | 7 | 128 | 49% |
| Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination | 2000 | 123 | 104 | 61% |
| Micro and Nanoparticle-Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective | 2013 | 28 | 199 | 38% |
| Applications of nanotechnology for immunology | 2013 | 57 | 131 | 21% |
| Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine | 2012 | 37 | 163 | 38% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ADJUVANT UNIT | 11 | 100% | 0.4% | 6 |
| 2 | CDDR | 9 | 83% | 0.3% | 5 |
| 3 | INFECT DIS IMMUNOL VACCINE DELIVERY FORMUL | 9 | 83% | 0.3% | 5 |
| 4 | VACCINE NANOTECHNOL | 8 | 75% | 0.4% | 6 |
| 5 | PLA BIOPHARMACEUT PROD FORMULAT ENGN | 5 | 50% | 0.5% | 7 |
| 6 | DRUG DELIVERY TECHNOL | 5 | 13% | 2.2% | 32 |
| 7 | BIOMED IBIV | 4 | 75% | 0.2% | 3 |
| 8 | PHARMACEUT TECHNOL MICROBIOL | 4 | 75% | 0.2% | 3 |
| 9 | DENT PHARM 3133 | 3 | 57% | 0.3% | 4 |
| 10 | UNIDADE PILOTO | 3 | 100% | 0.2% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000176739 | ISCOMS//ISCOM//QUIL A |
| 2 | 0.0000168233 | ALUMINUM HYDROXIDE ADJUVANT//ANTIGEN ADSORPTION//MACROPHAGIC MYOFASCIITIS |
| 3 | 0.0000156560 | FUSOGENIC LIPIDS//DRUG DELIVERY SYST DEV//B30 MDP |
| 4 | 0.0000123168 | PLGA//MICROSPHERES//POLYLACTIDE CO GLYCOLIDE |
| 5 | 0.0000120534 | M CELL//M CELLS//FOLLICLE ASSOCIATED EPITHELIUM |
| 6 | 0.0000120026 | VIROSOMES//FUSOGENIC LIPOSOME//VIROSOME |
| 7 | 0.0000116061 | CHOLERA TOXIN//HEAT LABILE ENTEROTOXIN//RECOMBINANT CHOLERA TOXIN B SUBUNIT RCTB |
| 8 | 0.0000083531 | CAROLINA CANC NANOTECHNOL EXCELLENCE//ARTIFICIAL ANTIGEN PRESENTING CELL//SLOAN KETTERING CANC |
| 9 | 0.0000068829 | N TRIMETHYL CHITOSAN CHLORIDE//CHITOSAN NANOPARTICLES//TRIPOLYPHOSPHATE |
| 10 | 0.0000066415 | CPG ODN//CPG MOTIF//CPG DNA |